2021 Fall Conference | C21 - Beyond the Bedside: What Are the Codes You’re Not Billing?
Program Materials Program Evaluations
| 05:30 PM - 05:50 PM EDT | Speaker |
Beyond the Bedside Part 1
Korwyn Williams, MD, PhD, FÂ鶹´«Ã½Ó³» |
| 05:50 PM - 06:06 PM EDT | Speaker |
Beyond the Bedside Part 2
Raissa Villanueva, MD, FÂ鶹´«Ã½Ó³» |
| 06:06 PM - 06:32 PM EDT | Speaker |
Beyond the Bedside Part 3
Neil A. Busis, MD, FÂ鶹´«Ã½Ó³» |
| 06:32 PM - 07:00 PM EDT | Q&A |
LIVE Q&A
Brad C. Klein, MD, MBA, FÂ鶹´«Ã½Ó³», Pearce J. Korb, MD, FÂ鶹´«Ã½Ó³», Korwyn Williams, MD, PhD, FÂ鶹´«Ã½Ó³», Raissa Villanueva, MD, FÂ鶹´«Ã½Ó³», Neil A. Busis, MD, FÂ鶹´«Ã½Ó³», David A. Evans, MBA, DÂ鶹´«Ã½Ó³» |
| Brad C. Klein, MD, MBA, FÂ鶹´«Ã½Ó³» | Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Pearce J. Korb, MD, FÂ鶹´«Ã½Ó³» | Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Â鶹´«Ã½Ó³» Resources. |
| Neil A. Busis, MD, FÂ鶹´«Ã½Ó³» | Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Â鶹´«Ã½Ó³». Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice. |
| Korwyn Williams, MD, PhD, FÂ鶹´«Ã½Ó³» | Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calcium and Company. |
| Raissa Villanueva, MD, FÂ鶹´«Ã½Ó³» | Dr. Villanueva has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria, consulting for CPT with Â鶹´«Ã½Ó³». Dr. Villanueva has received personal compensation in the range of $5,000-$9,999 for serving as a migraine research grant reviewer with American Headache Society. Dr. Villanueva has a non-compensated relationship as a Practice Management Committee CoChair with American Headache Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| David A. Evans, MBA, DÂ鶹´«Ã½Ó³» | Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI. |